Work

Supplementary Figure S7 from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling

Year: 2023

Type: supplementary-materials

Abstract: Absolute CD56+/CK- cell count distribution in the tumor compartment (A), the stromal compartment (B), and the entire TMA core (C); Percentage of CD56+/CK- cells in the stroma according to CB groups (D); Absolute CD56+/CK- cell counts according to clinical benefit groups (E)

DOI: 10.1158/1078-0432.22476978.v1

Authors: Jon Zugazagoitia, Swati Gupta, Yuting Liu, Kit Fuhrman, Scott Gettinger, Roy S. Herbst, Kurt A. Schalper, David L. Rimm

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361937589

Cites:

Cited by:

Related to: 10